{
    "organizations": [],
    "uuid": "f0ee96b9a7427457e2ac96405672f448826a8ca5",
    "author": "",
    "url": "https://www.reuters.com/article/brief-alnylam-reaches-settlement-agreeme/brief-alnylam-reaches-settlement-agreement-with-dicerna-pharmaceuticals-idUSFWN1RX0U6",
    "ord_in_thread": 0,
    "title": "BRIEF-Alnylam Reaches Settlement Agreement With Dicerna Pharmaceuticals",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 20, 2018 / 4:50 PM / in 30 minutes BRIEF-Alnylam Reaches Settlement Agreement With Dicerna Pharmaceuticals Reuters Staff \nApril 20 (Reuters) - Alnylam Pharmaceuticals Inc: \n* ALNYLAM REACHES SETTLEMENT AGREEMENT WITH DICERNA PHARMACEUTICALS RESOLVING TRADE SECRET MISAPPROPRIATION AND OTHER PENDING LITIGATION \n* ALNYLAM PHARMACEUTICALS INC - UNDER TERMS OF AGREEMENT, DICERNA WILL PAY $25 MILLION COMPRISED OF CASH AND STOCK TO ALNYLAM \n* ALNYLAM PHARMACEUTICALS INC - SETTLEMENT DOES NOT INCLUDE ANY LICENSE TO ALNYLAM’S GALNAC CONJUGATE INTELLECTUAL PROPERTY \n* ALNYLAM - AS PER SETTLEMENT, DICERNA WILL BE RESTRICTED IN ITS DEVELOPMENT RELATING TO OLIGONUCLEOTIDE-BASED THERAPEUTICS FOR A DEFINED SET OF CO’S TARGETS \n* ALNYLAM PHARMACEUTICALS - ALL OTHER SETTLEMENT TERMS ARE CONFIDENTIAL Source text for Eikon: Further company coverage:",
    "published": "2018-04-20T19:49:00.000+03:00",
    "crawled": "2018-04-20T20:29:28.018+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "pm",
        "minute",
        "reach",
        "settlement",
        "agreement",
        "dicerna",
        "pharmaceutical",
        "reuters",
        "staff",
        "april",
        "reuters",
        "alnylam",
        "pharmaceutical",
        "inc",
        "alnylam",
        "reach",
        "settlement",
        "agreement",
        "dicerna",
        "pharmaceutical",
        "resolving",
        "trade",
        "secret",
        "misappropriation",
        "pending",
        "litigation",
        "alnylam",
        "pharmaceutical",
        "inc",
        "term",
        "agreement",
        "dicerna",
        "pay",
        "million",
        "comprised",
        "cash",
        "stock",
        "alnylam",
        "alnylam",
        "pharmaceutical",
        "inc",
        "settlement",
        "include",
        "license",
        "alnylam",
        "galnac",
        "conjugate",
        "intellectual",
        "property",
        "alnylam",
        "per",
        "settlement",
        "dicerna",
        "restricted",
        "development",
        "relating",
        "therapeutic",
        "defined",
        "set",
        "co",
        "target",
        "alnylam",
        "pharmaceutical",
        "settlement",
        "term",
        "confidential",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}